Prime Therapeutics receives award for security innovation leadership - Prime Therapeutics
Prime Therapeutics receives award for security innovation leadership
2025 CSO Awards recognize industry-leading initiatives, specifically related to artificial intelligence governance and innovation
Cybersecurity is an increasingly important topic in the health care industry, as 92% of health care organizations faced cyberattack threats in the past year, up 88% from 2023. Central to this conversation is the evolution of artificial intelligence (AI), which 94% of health care companies say they use in some form, according to a 2023 Morgan Stanley Research survey.
Prime Therapeutics (Prime) continues to lead the industry when it comes to information technology (IT) innovation and balancing technological advancement with responsible governance. These efforts were recently recognized with a 2025 Chief Security Officer (CSO) Award, which honors organizations that demonstrate excellence in security and risk management, showcasing innovative security strategies and offering significant business value.
“The role of cybersecurity professionals in today's landscape has become much more nuanced with the expansion of AI and the threats it can pose,” said Cam Kracke, vice president, chief information security officer. “We are honored to receive this award that recognizes our accomplishments.”
Launched in 2023, Prime’s award-winning program established two key bodies to support the company’s IT innovation work:
- An AI governance body to oversee risk and compliance.
- An AI enablement team to accelerate experimentation and deployment.
These groups help create a safe and flexible framework for managing AI in health care, allowing for innovation while keeping risks in check.
“This award recognizes the collaborative efforts of teams across IT, information security, legal, privacy, business operations and more,” said Craig Johnson, vice president, IT enterprise technology transformation and operations. “I’m proud of our teams and what we’ve been able to accomplish by working together.”
“Achieving our bold purpose requires creativity, efficiency and innovation,” Kracke added. “We know that the responsible use of AI can help us revolutionize member and patient care. Our award-winning foundation advances this work, allowing us to challenge the status quo while upholding the highest standards of privacy, security and ethical development.”
Read the full list of award recipients.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.